<p>NNRTI: non nucleoside reverse transcriptase inhibitors, NRTI: nucleoside reverse transcriptase inhibitors.</p
<p>N(<b>t</b>)RTI – nucleoside(tide) reverse transcriptase inhibitor; NNRTI – non-nucleoside reverse...
<p>HIV-1 Drug Resistance mutations against nucleotide reverse transcriptase inhibitors (NRTI), non-n...
<p>Percentage of sequences having resistance mutations to NRTI (red), NNRTI (yellow), PI (green), an...
<p>Abbreviations: NRTI; nucleoside reverse transcriptase inhibitor, NNRTI; non-nucleoside reverse tr...
<p>Absolute and cumulative prevalence of each major nucleoside (NRTI) and nonnucleoside RT inhibitor...
<p>(A) NRTI resistance mutations; thymidine analog mutations (TAMs) are in light grey. (B) NNRTI res...
<p>Frequency of Nucleoside Reverse Transcriptase Inhibitor-related drug resistance mutations [A], Fr...
<p>NRTI: nucleoside reverse transcriptase inhibitors; NNRTI: non-nucleoside reverse transcriptase in...
<p>Nucleoside/tide Reverse Transcriptase Inhibitor (NRTI) mutation profiles associated with failure ...
<p>DRM: Drug resistance mutations; NRTI: Nucleoside/Nucleotide Reverse Transcriptase Inhibitors; NNR...
ObjectivesThe introduction of two new non-nucleoside reverse transcriptase inhibitors (NNRTIs) in th...
<p>Absolute and cumulative prevalence of each major nucleoside (NRTI) and nonnucleoside RT Inhibitor...
<p>TDR, transmitted drug resistance; NRTI, nucleoside reverse transcriptase inhibitors; NNRTI, non-n...
<p>250 samples from 234 drug-naive patients and 115 samples from 78 treated A/AE patients were genot...
<p>IAS-USA, the international Antiviral society-USA; NRTI, nucleoside reverse transcriptase inhibito...
<p>N(<b>t</b>)RTI – nucleoside(tide) reverse transcriptase inhibitor; NNRTI – non-nucleoside reverse...
<p>HIV-1 Drug Resistance mutations against nucleotide reverse transcriptase inhibitors (NRTI), non-n...
<p>Percentage of sequences having resistance mutations to NRTI (red), NNRTI (yellow), PI (green), an...
<p>Abbreviations: NRTI; nucleoside reverse transcriptase inhibitor, NNRTI; non-nucleoside reverse tr...
<p>Absolute and cumulative prevalence of each major nucleoside (NRTI) and nonnucleoside RT inhibitor...
<p>(A) NRTI resistance mutations; thymidine analog mutations (TAMs) are in light grey. (B) NNRTI res...
<p>Frequency of Nucleoside Reverse Transcriptase Inhibitor-related drug resistance mutations [A], Fr...
<p>NRTI: nucleoside reverse transcriptase inhibitors; NNRTI: non-nucleoside reverse transcriptase in...
<p>Nucleoside/tide Reverse Transcriptase Inhibitor (NRTI) mutation profiles associated with failure ...
<p>DRM: Drug resistance mutations; NRTI: Nucleoside/Nucleotide Reverse Transcriptase Inhibitors; NNR...
ObjectivesThe introduction of two new non-nucleoside reverse transcriptase inhibitors (NNRTIs) in th...
<p>Absolute and cumulative prevalence of each major nucleoside (NRTI) and nonnucleoside RT Inhibitor...
<p>TDR, transmitted drug resistance; NRTI, nucleoside reverse transcriptase inhibitors; NNRTI, non-n...
<p>250 samples from 234 drug-naive patients and 115 samples from 78 treated A/AE patients were genot...
<p>IAS-USA, the international Antiviral society-USA; NRTI, nucleoside reverse transcriptase inhibito...
<p>N(<b>t</b>)RTI – nucleoside(tide) reverse transcriptase inhibitor; NNRTI – non-nucleoside reverse...
<p>HIV-1 Drug Resistance mutations against nucleotide reverse transcriptase inhibitors (NRTI), non-n...
<p>Percentage of sequences having resistance mutations to NRTI (red), NNRTI (yellow), PI (green), an...